Targeted next-generation sequencing-based sequencing of cell-free DNA in cerebrospinal fluid uncovers cancer-specific

Alexander Köpp1, Peter Westarp2, Marta Nowak3

  • 1Department of Neurology, Clinical Neuroscience Center, University Hospital Zurich and University of Zurich, Zurich, Switzerland.

Neuro-Oncology Advances
|February 10, 2026
PubMed
Abstract

Insights

Targeted sequencing of cell-free DNA in cerebrospinal fluid (CSF) shows promise for diagnosing brain tumors when biopsies are not feasible. This liquid biopsy approach aids in detecting cancer-specific mutations, facilitating timely diagnosis and treatment.

Area of Science:

  • Neuro-oncology
  • Genomics
  • Molecular Diagnostics

Background:

  • Neurosurgical biopsies are the standard for brain tumor diagnosis but can be limited by tumor location.
  • Alternative diagnostic methods are needed for inaccessible brain tumors.
  • Cell-free DNA (cfDNA) analysis offers a potential non-invasive diagnostic approach.

Purpose of the Study:

  • To evaluate the clinical utility of targeted sequencing of cfDNA in cerebrospinal fluid (CSF) and blood for brain tumor detection.
  • To assess if this method can identify cancer-specific mutations using a standard gene panel.
  • To determine if cfDNA sequencing can aid in diagnosing brain tumors, especially when biopsies are challenging.

Main Methods:

  • Patients with suspected or confirmed CNS tumors or leptomeningeal metastasis were enrolled.
  • CSF and blood samples were collected for cfDNA extraction.
  • Next-generation sequencing (NGS) was used for targeted sequencing of cfDNA, with matched tissue sequencing when available.

Main Results:

  • Sequencing was successful in 55% of CSF samples and 100% of blood samples.
  • CSF cfDNA analysis detected more tumor-specific mutations than blood analysis on average.
  • Successful CSF sequencing correlated with tumors closer to the CSF space and larger tumor size.
  • CSF sequencing aided diagnosis in two high-surgical-risk cases, identifying primary CNS lymphoma and H3 K27M diffuse midline glioma.

Conclusions:

  • NGS-based targeted sequencing of cfDNA in CSF holds significant potential for diagnosing brain tumors.
  • This approach can facilitate diagnosis in patients with new cerebral lesions, particularly when conventional biopsies are not feasible.
  • CSF cfDNA sequencing represents a promising advancement in neuro-oncology diagnostics.

Related Concept Videos

Next-generation Sequencing03:00

Next-generation Sequencing

The first human genome sequencing project cost $2.7 billion and was declared complete in 2003, after 15 years of international cooperation and collaboration between several research teams and funding agencies. Today, with the advent of next-generation sequencing technologies, the cost and time of sequencing a human genome have dropped over 100 fold.
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features....
98.8K
Cis-regulatory Sequences02:02

Cis-regulatory Sequences

Cis-regulatory sequences are short fragments of non-coding DNA that are present on the same chromosomes as the genes that they regulate. These fragments serve as binding sites for transcriptional regulators, proteins that are responsible for controlling gene transcription and differential gene expression across cell types in eukaryotes. Cis-regulatory sequences can be close to the gene of interest or thousands of bases away in the DNA sequence; however, those sequences that are further away are...
11.9K
Cerebrospinal Fluid01:21

Cerebrospinal Fluid

Cerebrospinal fluid (CSF) is a colorless liquid that flows around the brain and the spinal cord, playing a vital role in the protection, support, and overall function of the central nervous system (CNS). CSF production, circulation, and absorption are tightly regulated processes essential for the brain and spinal cord to function properly.
CSF Production
CSF is produced mainly in the choroid plexus, a network of capillaries and ependymal cells located within the ventricular system of the brain....
6.1K
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
15.0K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.0K
Sequences01:29

Sequences

Sequences are fundamental mathematical objects consisting of ordered lists of numbers that follow a specific rule or pattern. Sequences are critical in various mathematical concepts, including calculus, series, and number theory. They can model real-world phenomena such as population growth, financial investments, and physical processes like the diminishing height of a bouncing ball.Each number in a sequence is referred to as a term. Typically, the terms are denoted as a1, a2, a3,…, where...
285